Updates and news related to prostate cancer:
AI-Powered Platform Officially Enters US Prostate Cancer Market
Physicians are now using the AI-powered Unfold AI platform to work with patients on treatment selection and establishing an optimal overall management plan.
Classifying Prostate Cancer Subtypes from Liquid Biopsies
There is a promising noninvasive alternative to needle biopsies: a “liquid biopsy” from blood, a diagnostic methodology that detects and characterizes DNA released from tumor cells.
The Use of Darolutamide in Patients with Castration-Resistant Prostate Cancer
Key data concerning the use of darolutamide in patients with castration-resistant CRPC, with a focus on safety and patient quality of life
Can a Healthy Diet Prevent Prostate Cancer?
Adhering to healthy diets seems to have no effect on prostate cancer risk, but following an unhealthy diet might increase the risk of developing aggressive prostate cancer.
Can Explainable AI Enhance Diagnosis and PI-RADS Classification of Prostate Cancer on MRI?
In a study of over 1,200 men with over 3,200 prostatic lesions, an explainable artificial intelligence (AI) model demonstrated a sensitivity rate of 93 percent for detecting clinically significant prostate cancer.
Active Surveillance for Low and Intermediate-Risk Prostate Cancer on the Rise
Use of active surveillance (AS) increased to approximately 60 percent for low-risk and 20 percent for favorable intermediate-risk prostate cancer from 2010 to 2018, according to a research letter published online April 3 in JAMA Internal Medicine.
New Blood Test Could Catch Prostate Cancer Early
A new blood test could help detect prostate cancer by looking at sugar levels.
Prostate Cancer on the Rise for Black Men
Where you live plays a role in cancer rate.
Low Risk Prostate Cancer
Has active surveillance become the new standard of care?
Prostate Cancer Foundation-Funded Research Identifies Promising Precision Immunotherapy Approach for Advanced Prostate Cancer
Study defines a mechanism by which prostate cancer cells resist immunotherapy and a possible new approach to reprogram them in an aggressive form of advanced disease.